Joe Bolen

Joe Bolen

Vorstandsvorsitzender bei
Orna Therapeutics, Inc.
72 Jahre
Health Technology
Consumer Services
Finance

Profil

Joseph B. Bolen is currently Chief Executive Officer at Orna Therapeutics, Inc. starting in 2025 and serves as an Independent Director at Aelin Therapeutics NV.
Formerly, Dr. Bolen was Chief Scientific Officer at PureTech Health Plc from 2016 to 2023, Partner at MPM BioImpact LLC in 2026, President & Chief Scientific Officer at Moderna, Inc. and ModernaTX, Inc., Vice President & Head-Oncologic Diseases at Hoechst Marion Roussel, Inc., Advisor at Robert Wood Johnson Medical School, Scientist at National Institutes of Health, Professor & Member-Graduate Faculty at Princeton University, Member-Scientific Advisory Board at Rutgers State University of New Jersey, Chief Scientific Officer & Head-Oncology Research at Millennium Pharmaceuticals, Inc., Founding Director at DNAX Research, Inc., and Director-Cellular Signaling Department at Bristol-Myers Squibb Pharma Research Labs LLC in 2012.
Education includes undergraduate studies at the University of Nebraska and a doctorate from Kansas State University.

Aktive Positionen von Joe Bolen

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Vorstandsvorsitzender 31.03.2025

Ehemalige bekannte Positionen von Joe Bolen

UnternehmenPositionEnde
Private Equity Investor 01.06.2026
PURETECH HEALTH PLC Technik-/Wissenschafts-/F&E-Leiter 01.02.2023
MODERNA, INC. Präsident -
Technik-/Wissenschafts-/F&E-Leiter -
DNAX Research, Inc.
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Joe Bolen im Detail an

Ausbildung von Joe Bolen

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

11

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen16

Health Technology

Consumer Services

Finance

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Government

Consumer Services

Health Technology

DNAX Research, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology